Portal de Periódicos da CAPES

Cost-effectiveness of an invasive strategy in unstable coronary artery disease. Results from the FRISC II invasive trial

2002; Oxford University Press; Volume: 23; Issue: 1 Linguagem: Inglês

10.1053/euhj.2001.2695

1522-9645

Magnus Janzon,

Cardiac Imaging and Diagnostics

Aims The utilization and timing of revascularization in unstable coronary artery disease varies, which could have important consequences for patients and for treatment costs. The FRISC II invasive trial compared an early invasive strategy vs a non-invasive strategy with respect to the composite end-point of death and myocardial infarction as well as costs.